Difference between revisions of "Clarification on comments re Biomarker.name"
(Created page with "__NOTOC__ Return to BRIDG ===Need clarification on comments re Biomarker.name (row 22)=== ====Current Definitions==== '''Biomarker''' DEFINITION: A measurable and qua...") |
|||
| Line 41: | Line 41: | ||
====Responses==== | ====Responses==== | ||
| − | + | Lauren Becnel: For protein examples, they are suggesting that you prepend each example with p. p.G48V says that there is a change at the 48th position in a protein from aa G to V. For non-protein examples, you would not use the p. All of your examples look like proteins, which again raises the question about scope & if it’s limited to genomics or inclusive other other CLIA-certified omics tests. | |
| + | See http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=5755 | ||
| + | |||
| + | DISCUSSION 20160223 (TYPE: EX): add "p." to all example values since currently they are all proteins, other values can be added later when the scope question Lauren raises is addressed, but at least our extant values will be accurate. | ||
| + | |||
| + | UPDATES DONE IN THE MODEL | ||
Return to [[BRIDG]] | Return to [[BRIDG]] | ||
Revision as of 05:34, 24 February 2016
Return to BRIDG
Need clarification on comments re Biomarker.name (row 22)
Current Definitions
Biomarker
DEFINITION: A measurable and quantifiable biological parameter which serves as index for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc. [Source: adapted from MESH]
EXAMPLE(S): Specific enzyme concentration, Specific hormone concentration, Specific gene phenotype distribution in a population, Presence of biological substances
OTHER NAME(S):
NOTE(S):
Biomarker.name
DEFINITION: The textual identifier for the biomarker as provided by the assigning source.
EXAMPLE(S): G48V, L10I, K20R, M36I, A71V, V82T
OTHER NAME(S):
NOTE(S):
Ballot Comment
examples all list variants using old standard for amino acid nomenclature. Recommend adding p. and moving it from biomarker to common name or alias, because the biomarker definition specifies a known association between genotype and phenotype. That is, even for variants of unknown significance the alias representation should be listed.
Current Disposition
Pending Input From Submitter
Proposed Disposition Comment
Need clarification - is this saying we should add "p." before or after the example values and change the attribute name from "name" to "commonName" or "alias"? The reasoning for the apparent name change is not clear, can submitter explain or rephrase?
Outstanding Questions
- What should the example value be?
- What should the attribute name be?
- Can the rationale be clarified?
Responses
Lauren Becnel: For protein examples, they are suggesting that you prepend each example with p. p.G48V says that there is a change at the 48th position in a protein from aa G to V. For non-protein examples, you would not use the p. All of your examples look like proteins, which again raises the question about scope & if it’s limited to genomics or inclusive other other CLIA-certified omics tests. See http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=5755
DISCUSSION 20160223 (TYPE: EX): add "p." to all example values since currently they are all proteins, other values can be added later when the scope question Lauren raises is addressed, but at least our extant values will be accurate.
UPDATES DONE IN THE MODEL
Return to BRIDG
